Quick Answer
ImageneBio, Inc. reported Diluted EPS of $9.64 per share (loss) for fiscal year 2025.
ImageneBio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$9.64 | +56.4% |
| 2024 | -$22.10 | -1255.8% |
| 2023 | -$1.63 | +14.2% |
| 2022 | -$1.90 | -55.7% |
| 2021 | -$1.22 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.91 | -12.8% | -4750.0% |
| June 30, 2025 | -$0.06 | +78.6% | +66.7% |
| March 31, 2025 | -$0.18 | +45.5% | +93.0% |
| September 30, 2024 | -$2.58 | -545.0% | -821.4% |
| June 30, 2024 | -$0.28 | +36.4% | +15.2% |
| March 31, 2024 | -$0.33 | +15.4% | +17.5% |
| September 30, 2023 | -$0.40 | +16.7% | +9.1% |
| June 30, 2023 | -$0.44 | +22.8% | -12.8% |
- ImageneBio, Inc. showed an increase of +56.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, ImageneBio, Inc.’s diluted eps has declined by 690.2% (from $1.22 per share (loss) to $9.64 per share (loss)).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: